$KYTX
Kyverna Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Emeryville, CA
KYTX chart
What traders are saying about $KYTX
Latest postsKyverna Therapeutics, Inc. news
- Kyverna Therapeutics Q3 2026 Earnings Date and Estimates
MarketBeat ·
- Kyverna Therapeutics, Inc. (KYTX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Kyverna Therapeutics Announces Publication of Registrational...
Quantisnow ·
- Kyverna Therapeutics Announces Publication of Registrational Miv-cel Data in Patients with Stiff Person Syndrome in JAMA Neurology
Yahoo Finance ·
- Kyverna Therapeutics Announces JAMA Neurology Publication of Registrational Miv-cel Data in Stiff Person Syndrome
Market.us ·
- Kyverna Therapeutics (KYTX) Institutional Ownership 2026 $KYTX
MarketBeat ·
- Kyverna Therapeutics, Inc. expected to post a loss of 69 cents a share - Earnings Preview
TradingView ·
- Kyverna Therapeutics, Inc. $KYTX Stock: AIGH Capital Management LLC Grows Holdings
MarketBeat ·
- Kyverna Therapeutics, Inc. (KYTX) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- Kyverna Therapeutics to Present at the Jefferies London Healthcare Conference
Yahoo Finance ·
- Kyverna Therapeutics (KYTX) Projected to Post Quarterly Earnings on Wednesday
MarketBeat ·
- Kyverna Therapeutics Presents Full One-Year Registrational Data Set Demonstrating Sustained Clinical Benefit of Miv-cel in Stiff Person Syndrome at MS Toronto
Yahoo Finance ·
Kyverna Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net income | -$161.3M | -$127.5M | -$60.4M |
| Diluted EPS | $-3.64 | $-3.33 | $-89.61 |
| Total assets (year end) | $293.8M | $304.6M | $75.2M |
| Cash and equivalents (year end) | $124.1M | $96.6M | $34.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Kyverna Therapeutics, Inc.
- Ticker
- KYTX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Emeryville, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1994702
- Former names
- Kyverna Therapeutics, Inc.
Frequently asked questions
What exchange is Kyverna Therapeutics, Inc. listed on?
Kyverna Therapeutics, Inc. trades on the Nasdaq under the ticker symbol KYTX.
What industry is Kyverna Therapeutics, Inc. in?
Kyverna Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Kyverna Therapeutics, Inc. headquartered?
Kyverna Therapeutics, Inc.'s business address on file with the SEC is in Emeryville, CA.
When does Kyverna Therapeutics, Inc.'s fiscal year end?
Kyverna Therapeutics, Inc.'s fiscal year ends on December 31.